Skip to main content

Table 1 Characteristics of studies included in the meta-analysis

From: The association between polymorphisms in the MDR1 gene and risk of cancer: a systematic review and pooled analysis of 52 case–control studies

References

First author’s name

Year of publication

Country of origin

Cancer type

Ethnicity

SNPs

Source of control groups

Matching criteria

Genotyping methods

Case

control

MAF

HWE

18

Rong-rong Liu

2008

Hunan, China

ALL

Asian

C3435T,C1236T,G2677T,G2677A

HB

Age, gender, weight

PCR-RFLP

48

100

0.17;0.24;0.04

0.60;0.21;0.07

19

Zhi-zhuo Du

2010

Suzhou, China

ALL

Asian

C3435T,C1236T,G2677T/A

HB

Age, gender

SNP-shot

176

170

0.30;0.38;0.27

0.00;0.28;0.23

2

Kevin Y. Urayama

2007

Northern and Central California, USA

ALL

 

C3435T,C1236T,G2677T/A

HB

Age, gender, Hispanic status

PCR-SBEP

294

369

0.25;0.21;0.18

0.30;0.13;0.18

3

Hiroyoshi Hattori

2007

Japan

ALL

Asian

C3435T

HB

Age, gender

Taqman

622

96

0.18

0.3

20

Jamroziak K

2004

Poland

ALL

Caucasian

C3435T

PB

Age, gender,

PCR-RELP

113

175

0.24

0

21

Evelia Leal-Ugarte

2008

Mexico

ALL

 

C3435T

PB

Gender

PCR-RELP

107

111

0.28

0.02

22

A’ gnes F. Semsei

2008

Hungary

ALL

Caucasian

C3435T,G2677T/A

PB

Age, gender, risk group

PCR-RELP

378

189

0.29;0.28

0.07;0.13

23

Vibeke Andersen

2009

Danish

colorectal cancer

Caucasian

C3435T,G-rs3789244-A

PB

Age, Gender,

TaqMan

359

765

0.33

0.47

24

Daniele Campa

2012

Czech Republic

colorectal cancer

Caucasian

C3435T

HB

Age, Gender,

Taqman

699

622

0.29

0.79

24

Daniele Campa

2012

Southwest Germany

colorectal cancer

Caucasian

C3435T

HB

Age, Gender, county of residence

Taqman

1809

1853

0.28

0.91

24

Daniele Campa

2012

Southwest Germany

colorectal cancer

Caucasian

C3435T

PB

Age, Gender,

Taqman

2169

1634

0.29

0.62

25

Urosˇ Potocnik

2008

Slovenia

MSI-H colorectal cancer

Caucasian

C3435T,C1236T,G2677T

HB

Age, Gender,

TaqMan

38

355

0.30;0.18;0.19

0.66;0.33;0.24

26

Nizar M Mhaidat

2011

Jordan

HL

Asian

C3435T

HB

Age

PCR-RFLP

130

120

0.35

0.11

27

Sun-Young Bae

2006

Korea

colorectal cancer

Asian

C3435T

HB

Age, Gender,

PCR-RFLP

111

93

0.16

0.01

28

Azam Khedri

2011

Iran

colorectal cancer

Caucasian

C3435T

HB

Age, Gender,

PCR-RFLP

118

137

0.35

0.56

29

Mateusz Kurzawski

2005

Poland

colorectal cancer

Caucasian

C3435T

HB

Age, Gender,

PCR-RFLP

184

188

0.29

0.27

30

Chiko Komoto

2006

Japan

colorectal cancer

Asian

C3435T,C1236T,G2677T

HB

Age, Gender,

TaqMan

48

154

0.16;0.375;0.36

0.62;0.36;0.37

30

Chiko Komoto

2006

Japan

esophageal squamous cell carcinoma

Asian

C3435T,C1236T,G2677T

HB

Age, Gender,

TaqMan

47

154

0.17;0.39;0.34

0.66;0.34;0.64

31

Bo-In Lee

2006

Korea

colorectal cancer

Asian

C3435T

HB

Age, Gender,

PCR-RFLP

64

64

0.13

0.15

32

Elena Osswald

2006

Russia

colorectal cancer

Caucasian

C3435T,G2677T/A

HB

Age, Gender, Smoking intensity

PCR-RFLP

285

275

0.26;0.20

0.35;0.42

33

Mariusz Panczyk

2009

Poland

colorectal cancer

Caucasian

C3435T,C1236T,G2677T

HB

Age, Gender,

PCR-RFLP

95

95

0.20;0.17;0.18

0.99;0.72;0.60

34

Darinka Todorova Petrova

2008

Bulgaria

colorectal cancer

Caucasian

C3435T,G2677T

HB

Age, Gender,

RT-PCR

146

160

0.25;0.21

0.73;0.32

35

J Sainz

2011

South Germany

colorectal cancer

Caucasian

C3435T

PB

Age, Gender,

PCR

1765

1784

0.27

0.6

36

Cizmarikova

2010

Eastern Slovakia

breast cancer

Caucasian

C3435T

PB

Age, Gender,

PCR-RFLP

221

113

0.27

0.6

37

M. Taheri

2010

Iran

breast cancer

Caucasian

C3435T

HB

Age, Gender,

PCR-RFLP

54

50

0.26

0.61

38

Tatari F

2009

North east of Iran

breast cancer

Caucasian

C3435T

HB

Gender,

PCR

106

77

0.29

0.59

39

Joseph George

2009

India

breast cancer

Asian

C3435T

HB

Gender,

PCR

86

68

0.15

0.7

40

Henriquez-Hernandez

2009

Spain

breast cancer

Caucasian

C3435T

HB

Gender,

PCR-RFLP

135

301

0.19

0.66

41

Nordgard

2007

Norway

breast cancer

Caucasian

C3435T,C1236T,G2677T/A

N.A.

Age, Gender,

PCR-RFLP

109

93

0.13;0.26;0.26

0.27;0.16;0.03

42

Sebahat Turgut

2007

Turkey

breast cancer

Caucasian

C3435T

PB

Gender,

PCR-RFLP

57

50

0.24

0.62

43

Wu H

2012

China

breast cancer

Asian

C3435T,C1236T,G2677T/A

PB

Age, Gender,

PCR-RFLP

1173

1244

0.17;0.41;0.17

0.01;0.04;0.94

44

Z Sabahi

2010

Iran

Gastric cancer

Caucasian

C3435T

PB

Age, Gender,

PCR

48

131

0.3

0.58

45

Mitsushige Sugimoto

2008

Japan

Gastric cancer

Asian

C3435T

HB

Age, Gender,

PCR-RFLP

150

168

0.17

0.68

46

Tomomitsu Tahara

2006

Japan

Gastric cancer

Asian

C3435T

HB

Age, Gender,

PCR-RFLP

157

104

0.21

0.64

47

P.M. MROZIKIEWICZ

2007

Poland

endometrial cancer

Caucasian

C3435T

PB

Age, Gender,

PCR

198

488

0.26

0.61

48

Federica Gemignani

2007

six Central and Eastern European countries

lung cancer

Caucasian

C3435T,G2677T/A

HB

Age, Gender,

TaqMan

299

317

0.24;0.21

0.62;0.01

49

S Haenisch

2007

Germany

renal cell cancer

Caucasian

C3435T,G2677T/A

PB

Age, Gender,

PCR-RFLP

82

164

0.31;0.22

0.58;0.14

50

Krzysztof Jamroziak

2006

Poland

AML

Caucasian

C3435T

PB

Age, Gender,

PCR-RFLP

180

180

0.23

0.64

51

Katie L. Miller

2005

USA

Glioma

Caucasian

C3435T

PB

Age, Gender,

PCR-RFLP

382

464

0.25

0.61

52

Krzysztof Jamroziak

2006

Poland

B-cell CLL

Caucasian

C3435T

PB

Age, Gender,

PCR-RFLP

110

201

0.2

0.65

53

Michael Siegsmund

2002

Germany

clear cell renal cell carcinoma (CCRCC)

Caucasian

C3435T

PB

Age, Gender,

PCR-RFLP

179

150

0.29

0.59

53

Michael Siegsmund

2002

Germany

non-CCRCC

Caucasian

C3435T

PB

Age, Gender,

PCR-RFLP

83

150

0.3

0.58

54

Guillermo Gervasini

2006

Spain

lung cancer

Caucasian

C3435T,G2677T/A

PB

Age, Gender,

TaqMan

96

86

0.26;0.31

0.61;0,。60

55

Soya Sisy Sam

2007

India

upper aerodigestive tract (UADT) cancers

Asian

C3435T

HB

Age, Gender,

PCR-RFLP

219

210

0.35

0.55

56

Krzysztof Jamroziak

2008

Poland

multiple myeloma

Caucasian

C3435T,C1236T,G2677T/A

PB

Age, Gender,

PCR-RFLP

111

96

0.19;0.15;0.18

0.66;0.01;0.55

57

V Rocha

2008

France

leukemia

Caucasian

C3435T

PB

Age, Gender,

PCR-RFLP

107

107

0.2

0.65

58

STEPHEN DRAIN

2009

UK

plasma cell myeloma

Caucasian

C3435T

PB

Age, Gender,

PCR-RFLP

92

92

0.28

0.6

59

G. Penna

2010

Italy

B-cell CLL

Caucasian

C3435T,G2677T

PB

Age, Gender,

PCR-RFLP

125

125

0.25;0.30

0.62;0.00

60

The MARIE-GENICA Consortium

2010

Germany

breast cancer

Caucasian

C3435T

PB

Age, Gender,

MALDI-TOFMS

3148

5486

0.22

0.64

61

HYUN CHANG

2009

Korea

Gastric cancer

Asian

C3435T,G2677T/A

PB

Age, Gender,

PCR

43

118

0.34;0.23

0.56;0.21

62

D Nageswara Rao

2010

India

AML

Asian

C3435T

PB

Age, Gender,

PCR-RFLP

143

249

0.28

0.6

62

D Nageswara Rao

2010

India

ALL

Asian

C3435T

PB

Age, Gender,

PCR-RFLP

147

249

0.37

0.54

  1. Abbreviations: HB: hospital-based; PB: population-based; PCR-RFLP: polymerase chain reaction-restriction fragment length polymorphism; MAF: minor allele frequency; APEX: arrayed primer extensions.